IJOC  Vol.3 No.1 , March 2013
Synthesis and in Vitro Cytotoxic Activity of Novel Pyrazole-3,4-dicarboxylates
ABSTRACT

N-Aryl-C-ethoxycarbonylnitrile imines (3a-g) react with ethyl cyanoacetate 1 in 1,3-dipolar cycloaddition to yield novel pyrazole-3,4-dicarboxylates (4a-g) in moderate yields. The reaction of pyrazole-3,4-dicarboxylates (4a, d) with hydrazine afforded pyrazolo[4,3-d]pyridazine-4,7-diones (5a, d) in good yields. All compounds were fully characterized by spectroscopic methods. Some of the newly synthesized compounds were evaluated for their cytotoxic activity against murine P815 mastocytoma cell line.


Cite this paper
H. Sekkak, E. Rakib, M. Abdelouahid, A. Hafid and A. Malki, "Synthesis and in Vitro Cytotoxic Activity of Novel Pyrazole-3,4-dicarboxylates," International Journal of Organic Chemistry, Vol. 3 No. 1, 2013, pp. 37-41. doi: 10.4236/ijoc.2013.31003.
References
[1]   B. K. Srivastava, A. Joharapurkar, S. Raval, J. Z. Patel, R. Soni, P. Raval, A. Gite, A. Goswami, N. Sadhwani, N. Gandhi, H. Patel, B. Mishra, M. Solanki, B. Pandey, M. R. Jain and P. R. Patel. “Diaryl Dihydropyrazole-3-carboxamides with Significant in Vivo Antiobesity Activity Related to CB1 Receptor Antagonism:?Synthesis, Biological Evaluation, and Molecular Modeling in the Homology Model,” Journal of Medicinal Chemistry, Vol. 50, No. 24, 2007, pp. 5951-5966. doi:10.1021/jm061490u

[2]   S. Yamamoto, N. Tomita, Y. Suzuki, T. Suzaki, T. Kaku, T. Hara, M. Yamaoka, N. Kanzaki, A. Hasuoka, A. Baba and M. Ito, “Design, Synthesis, and Biological Evaluation of 4-Arylmethyl-1-phenylpyrazole and 4-Aryloxy-1- phenylpyrazole Derivatives as Novel Androgen Receptor Antagonists,” Bioorganic & Medicinal Chemistry, Vol. 20, No. 7, 2012, pp. 2338-2352. doi:10.1016/j.bmc.2012.02.005

[3]   C. E. Mowbray, C. Burt, R. Corbau, M. Perros, I. Tran, P. A. Stupple, R. Webster and A. Wooda, “Pyrazole NNRTIs 1: Design and Initial Optimisation of a Novel Template,” Bioorganic & Medicinal Chemistry Letters, Vol. 19, No. 19, 2009, pp. 5599-5602. doi:10.1016/j.bmcl.2009.08.039

[4]   G. R. Bebernitz, G. Argentieri, B. Battle, C. Brennan, B. Balkan, B. F. Burkey, M. Eckhardt, J. Gao, P. Kapa, R. J. Strohschein, H. F. Schuster, M. Wilson and D. D. Xu, “The Effect of 1,3-Diaryl-[1H]-pyrazole-4-acetamides on Glucose Utili-zation in ob/ob Mice,” Journal of Medicinal Chemistry, Vol. 44, No. 16, 2001, pp. 2601-2611. doi:10.1021/jm010032c

[5]   A. A. Bekhit and T. Abdel-Aziem, “Design, Synthesis and Biological Evaluation of Some Pyrazole Derivatives as Anti-Inflammatory-Antimicrobial Agents,” Bioorganic & Medicinal Chemistry, Vol. 12, No. 8, 2004, 1935-1945. doi:10.1016/j.bmc.2004.01.037

[6]   D. V. Dekhane, S. S. Pawar, S. Gupta, M. S. Shingare, C. R. Patil and S. N. Thore, “Synthesis and Anti-Inflammatory Activity of Some New 4,5-Dihydro-1,5-diaryl-1Hpyrazole-3-substituted-heteroazole Derivatives,” Bioorganic & Medicinal Chemistry Letters, Vol. 19, No. 21, 2011, pp. 6527-6532. doi:10.1016/j.bmcl.2011.08.061

[7]   F. R. Souza, V. T. Souza, V. Ratzlaff, L. P. Borges, M. R. Oliveira, H. G. Bonacorso, N. Zanatta, M. A. P. Martins and C. F. Mello, “Hypothermic and Antipyretic Effects of 3-Methyl- and 3-Phenyl-5-hydroxy-5-trichloromethyl-4,5- dihydro-1H-pyrazole-1-carboxyamides in Mice,” Euro-pean Journal of Pharmacology, Vol. 451, No. 2, 2002, pp. 141-147. doi:10.1016/S0014-2999(02)02225-2

[8]   M. Iovu, C. Zalaru, F. Dumitrascu, C. Draghici, M. Moraru and E. Criste, “New Substituted 2-(Pyrazol-1-yl)- dialkylacetanilides with Potential Local Anesthetic and Antiarrhythmic Action,” Il Farmaco, Vol. 58, 2003, pp. 301-307.

[9]   X.-F. Huang, X. Lu, Y. Zhang, G.-Q. Song, Q.-L. He, Q.-S. Li, X.-H. Yang, Y. Wei and H.-L. Zhu, “Synthesis, Biological Evaluation, and Molecular Docking Studies of N-((1,3-Diphenyl-1H-pyrazol-4-yl)methyl)aniline Derivatives as Novel Anticancer Agents,” Bioorganic & Medicinal Chemistry, Vol. 20, 2012, pp. 4895-4900.

[10]   X. Li, X. Lu, M. Xing, X.-H. Yang, T.-T. Zhao, H.-B. Gong and H.-L. Zhu, “Synthesis, Biological Evaluation, and Molecular Docking Studies of N,1,3-Triphenyl-1Hpyrazole-4-carboxamide Derivatives as Anticancer Agents,” Bioorganic & Medicinal Chemistry Letters, Vol. 22, 2012, pp. 3589-3593.

[11]   F. Chimenti, R. Fioravanti, A. Bolasco, F. Manna, P. Chimenti, D. Secci, O. Befani, P. Tu-rini, F. Ortuso and S. Alcaro, “Monoamine Oxidase Isoform-Dependent Tautomeric Influence in the Recognition of 3,5-Diaryl Pyrazole Inhibitors,” Journal of Medicinal Chemistry, Vol. 50, No. 3, 2007, pp. 425-428. doi:10.1021/jm060868l

[12]   L.-L. Xu, C.-J. Zheng, L.-P. Sun, J. Miao and H.-R. Piao, “Synthesis of Novel 1,3-Diaryl Pyrazole Derivatives Bearing Rhodanine-3-fatty Acid Moieties as Potential Antibacterial Agents,” European Journal of Medicinal Chemistry, Vol. 48, 2012, pp. 174-178. doi:10.1016/j.ejmech.2011.12.011

[13]   J. Wen, Y. Fu, R.-Y. Zhang, J. Zhang, S.-Y. Chen and X.-Q. Yu, “A Simple and Efficient Synthesis of Pyrazoles in Water,” Tetrahedron, Vol. 67, No. 49, 2011, pp. 9618- 9621. doi:10.1016/j.tet.2011.09.074

[14]   M. V. Patel, R. Bell, S. Majest, R. Henry and T. Kolasa, “Synthesis of 4,5-Diaryl-1H-pyrazole-3-ol Derivatives as Potential COX-2 Inhibitors,” Journal of Organic Chemistry, Vol. 69, No. 21, 2004, pp. 7058-7065. doi:10.1021/jo049264k

[15]   S. T. Heller and S. R. Natarajan, “1,3-Diketones from Acid Chlorides and Ketones:? A Rapid and General One-Pot Synthesis of Pyrazoles,” Organic Letters, Vol. 8, 2006, pp. 2675-2678.

[16]   P. Conti, A. Pinto, L. Tamborini, V. Rizzo and C. D. Micheli, “A Regioselective Route to 5-Substituted Pyrazole- and Pyrazoline-3-phosphonic Acids and Esters,” Tetrahedron, Vol. 63, No. 25, 2007, pp. 5554-5560. doi:10.1016/j.tet.2007.04.027

[17]   V. K. Aggarwal, J. D. Vicente and R. V. Bonnert, “A Novel One-Pot Method for the Preparation of Pyrazoles by 1,3-Dipolar Cycloadditions of Diazo Compounds Generated in Situ,” Journal of Organic Chemistry, Vol. 68, No. 13, 2003, pp. 5381-5383. doi:10.1021/jo0268409

[18]   D. B. Sharp and C. S. Hamilton, “Derivatives of 1,2,4- Triazole and of Pyrazole,” Journal of the American Chemical Society, Vol. 68, No. 4, 1946, pp. 588-591. doi:10.1021/ja01208a018

[19]   S. Abouricha, E. M. Rakib, N. Benchat, M. Alaoui, H. Allouchi and B. El Bali, “Facile Synthesis of New Spirothiadiazolopyridazines by 1,3-Dipolar Cycloaddition,” Synthetic Communication, Vol. 35, No. 16, 2005, pp. 2213-2221; doi:10.1080/00397910500182697

[20]   H. Sekkak, S. Mojahidi, E. M. Rakib, S. Abouricha, A. Kerbal, C. Aiello and M. Viale, “Synthesis and Antiproliferative Evaluation Of Spirothiadiazolopyridazine Derivatives,” Letters in Drug Design & Discovery, Vol. 7, No. 10, 2010, pp. 743-746. doi:10.2174/1570180811007010743

[21]   T. Mossman, “Rapid Colorimetric Assay for Cellular Growth and Sur-vival: Application to Proliferation and Cytotoxicity Assays,” Journal of Immunological Methods Vol. 65, No. 1-2, 1983, pp. 55-63. doi:10.1016/0022-1759(83)90303-4

 
 
Top